<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Geuka Africa | Vivien Miles | Activity</title>
	<link>https://geuka.org/members/vivienmiles59/activity/</link>
	<atom:link href="https://geuka.org/members/vivienmiles59/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Vivien Miles.</description>
	<lastBuildDate>Wed, 10 Jun 2026 09:08:10 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">24678e94afeaad02d051849d30e8c1f3</guid>
				<title>Vivien Miles started the topic JWH-210 Wikipedia in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/jwh-210-wikipedia-4/</link>
				<pubDate>Thu, 04 Jun 2026 21:25:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoi</p>
<p>Such decrease remained 2 hr after the administration (Table 4). In locomotor activity,&hellip;<span class="activity-read-more" id="activity-read-more-206669"><a href="https://geuka.org/forums/topic/jwh-210-wikipedia-4/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">dfeca57eb5cf876591b2d358b4f2a5db</guid>
				<title>Vivien Miles started the topic 4FADB,4F-ADB, in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/4fadb4f-adb-4/</link>
				<pubDate>Thu, 04 Jun 2026 21:21:53 +0000</pubDate>

									<content:encoded><![CDATA[<p>Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act 2016. The corresponding indole core analogue, 4F-MDMB-BICA (4F-MDMB-BUTICA), has also&hellip;<span class="activity-read-more" id="activity-read-more-206666"><a href="https://geuka.org/forums/topic/4fadb4f-adb-4/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6b47048c182d77644e0ccb13b47b01c7</guid>
				<title>Vivien Miles started the topic Buy JWH-210 Online Premium Powder For Sale in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/buy-jwh-210-online-premium-powder-for-sale-2/</link>
				<pubDate>Thu, 04 Jun 2026 21:14:37 +0000</pubDate>

									<content:encoded><![CDATA[<p>When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC</p>
<p>Taken together&hellip;<span class="activity-read-more" id="activity-read-more-206661"><a href="https://geuka.org/forums/topic/buy-jwh-210-online-premium-powder-for-sale-2/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">72b4b6b1c77d4e3fe39ceeca0cfabf81</guid>
				<title>Vivien Miles started the topic Buy 5CL-ADB-A Online Lab Tested 99% Pure Research Chemical Powder 10g+ in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/buy-5cl-adb-a-online-lab-tested-99-pure-research-chemical-powder-10g-11/</link>
				<pubDate>Thu, 04 Jun 2026 21:10:48 +0000</pubDate>

									<content:encoded><![CDATA[<p>A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of ED50 values. During test sessions, both levers were active, such that ten consecutive responses on either lever led to JWH-210 powder reinforcement. The substitution tests&hellip;<span class="activity-read-more" id="activity-read-more-206658"><a href="https://geuka.org/forums/topic/buy-5cl-adb-a-online-lab-tested-99-pure-research-chemical-powder-10g-11/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">ebbd7139158ef656966c8ea439cb0210</guid>
				<title>Vivien Miles started the topic Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via. in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/monitoring-metabolism-of-synthetic-cannabinoid-4f-mdmb-binaca-via-2/</link>
				<pubDate>Tue, 26 May 2026 07:45:20 +0000</pubDate>

									<content:encoded><![CDATA[<p>Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity of the mice was measured 30 min and 2 hrs after the last substance administration. We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in&hellip;<span class="activity-read-more" id="activity-read-more-204432"><a href="https://geuka.org/forums/topic/monitoring-metabolism-of-synthetic-cannabinoid-4f-mdmb-binaca-via-2/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>